These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16480512)

  • 21. Progress in the control of prostate cancer in Rhode Island, 1987-2000.
    Chiaverini L; Fulton JP; Darcy DM
    Med Health R I; 2002 Sep; 85(9):291-3. PubMed ID: 12371217
    [No Abstract]   [Full Text] [Related]  

  • 22. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
    Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in prostate carcinoma incidence in Connecticut (1988-1994) by age and race.
    Polednak AP
    Cancer; 1997 Jan; 79(1):99-103. PubMed ID: 8988732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999.
    Oliver MN; Smith E; Siadaty M; Hauck FR; Pickle LW
    Am J Prev Med; 2006 Feb; 30(2 Suppl):S67-76. PubMed ID: 16458792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assisted reproductive technology surveillance--United States, 2011.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Barfield WD;
    MMWR Surveill Summ; 2014 Nov; 63(10):1-28. PubMed ID: 25412164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clustering in the incidence of myelodysplastic syndromes.
    Ma X; Selvin S; Raza A; Foti K; Mayne ST
    Leuk Res; 2007 Dec; 31(12):1683-6. PubMed ID: 17507092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer survival in five continents: a worldwide population-based study (CONCORD).
    Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
    Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in prostate cancer incidence and treatment in USA.
    Lu-Yao GL; Greenberg ER
    Lancet; 1994 Jan; 343(8892):251-4. PubMed ID: 7905093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [State of health of populations residing in geothermal areas of Tuscany].
    Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
    Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assisted Reproductive Technology Surveillance - 
United States, 2013.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
    MMWR Surveill Summ; 2015 Dec; 64(11):1-25. PubMed ID: 26633040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for prostate cancer in Rhode Island during National Prostate Cancer Awareness Week.
    Cohen SI; Kingston T
    R I Med; 1992 Nov; 75(11):523-5. PubMed ID: 1490020
    [No Abstract]   [Full Text] [Related]  

  • 33. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
    Patel VB; Nahar R; Murray B; Salner AL
    Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assisted reproductive technology surveillance -- United States, 2010.
    Sunderam S; Kissin DM; Crawford S; Anderson JE; Folger SG; Jamieson DJ; Barfield WD;
    MMWR Surveill Summ; 2013 Dec; 62(9):1-24. PubMed ID: 24304902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer incidence in guadeloupe, a French Caribbean archipelago.
    Mallick S; Blanchet P; Multigner L
    Eur Urol; 2005 Jun; 47(6):769-72. PubMed ID: 15925071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of increased prostate cancer screening in Rhode Island.
    Fulton JP
    Med Health R I; 2006 Aug; 89(8):288-90. PubMed ID: 16967662
    [No Abstract]   [Full Text] [Related]  

  • 37. Cluster detection methods applied to the Upper Cape Cod cancer data.
    Ozonoff A; Webster T; Vieira V; Weinberg J; Ozonoff D; Aschengrau A
    Environ Health; 2005 Sep; 4():19. PubMed ID: 16164750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: The Public Health Disparities Geocoding Project (US).
    Krieger N; Chen JT; Waterman PD; Soobader MJ; Subramanian SV; Carson R
    J Epidemiol Community Health; 2003 Mar; 57(3):186-99. PubMed ID: 12594195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeled exposure to tetrachloroethylene-contaminated drinking water and the occurrence of birth defects: a case-control study from Massachusetts and Rhode Island.
    Aschengrau A; Gallagher LG; Winter M; Butler L; Patricia Fabian M; Vieira VM
    Environ Health; 2018 Nov; 17(1):75. PubMed ID: 30400949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer and the Will Rogers phenomenon.
    Albertsen PC; Hanley JA; Barrows GH; Penson DF; Kowalczyk PD; Sanders MM; Fine J
    J Natl Cancer Inst; 2005 Sep; 97(17):1248-53. PubMed ID: 16145045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.